Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director James T. Treace acquired 50,000 shares of Treace Medical Concepts stock in a transaction dated Tuesday, May 28th. The stock was purchased at an average price of $5.07 per share, with a total value of $253,500.00. Following the completion of the purchase, the director now […]